HUBBLE BIOSCIENCES
Hubble Biosciences is an Oregon-based biotechnology company operating in stealth.
HUBBLE BIOSCIENCES
Industry:
Biotechnology Health Care
Address:
Portland, Oregon, United States
Country:
United States
Status:
Active
Similar Organizations
Nautilus Biosciences
Nautilus Biosciences, a marine biotechnology company.
Willow Neuroscience
Willow Neuroscience is a biotechnology company currently operating in stealth mode.
Current Employees Featured
Founder
More informations about "Hubble Biosciences"
Hubble Bioscience - Products, Competitors, Financials, Employees ...
Hubble Bioscience. Frequently Asked Questions (FAQ). When was Hubble Bioscience founded? Hubble Bioscience was founded in 2019. Where is Hubble Bioscience's headquarters? Hubble …See details»
Hubble Biosciences - Funding, Financials, Valuation & Investors
Hubble Biosciences is an Oregon-based biotechnology company operating in stealth. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. …See details»
Hubble Biosciences - Contacts, Employees, Board Members
Hubble Biosciences is an Oregon-based biotechnology company operating in stealth.See details»
Hubble Biosciences - Drug pipelines, Patents, Clinical trials - Synapse
Last update 19 Sep 2024. Hubble Biosciences. Private Company |See details»
HUBBLE BIOSCIENCE INC Portland OR, 97214 - Company Profile
Free Business profile for HUBBLE BIOSCIENCE INC at 3125 Se Belmont St, Portland, OR, 97214-4028, US. HUBBLE BIOSCIENCE INC specializes in: Commercial Physical and …See details»
Hubble Bioscience, Inc. | CipherBio
Explore Hubble Bioscience, Inc.'s investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Andelyn Biosciences Selected by Hubble Therapeutics to …
Oct 9, 2024 Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has been selected by …See details»
Press Release Archives - Hubble TX
Andelyn Biosciences Selected by Hubble Therapeutics to Manufacture Clinical Grade AAV for the Treatment of Leber Congenital Amaurosis (LCA16) by Margo | Oct 29, 2024 | Press Release. …See details»
Andelyn Biosciences Selected by Hubble Therapeutics to …
COLUMBUS, OH, October 9, 2024 - Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has been …See details»
Andelyn Biosciences Chosen by Hubble Therapeutics to …
Oct 11, 2024 €Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has been selected by …See details»
Hubble Therapeutics - Products, Competitors, Financials, …
Andelyn Biosciences Chosen by Hubble Therapeutics to Manufacture Gene Therapy for Rare Childhood Blindness Disorder. Oct 11, 2024. 11 October 2024 | News Andelyn’s AAV …See details»
Hubble Biosciences - Crunchbase
Hubble Biosciences is an Oregon-based biotechnology company operating in stealth.See details»
Seed Round - Hubble Biosciences - 2022-06-03 - Crunchbase
Jun 3, 2022 Hubble Biosciences raised an undisclosed amount on 2022-06-03 in Seed Round. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. …See details»
Andelyn Biosciences Selected by Hubble Therapeutics to …
COLUMBUS, OH, October 9, 2024 – Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has been …See details»
Hubble and Andelyn Join Forces for Vision Therapy!
Oct 14, 2024 The partnership between Hubble Therapeutics and Andelyn Biosciences represents a significant step towards addressing the unmet needs of patients with LCA16. By …See details»
Hubble Therapeutics selects Andelyn Biosciences to manufacture …
Oct 11, 2024 President of Hubble Therapeutics, Jeff Sabados, commented: “Over the past 18 months we have identified best-in-class partners including Andelyn Biosciences to establish a …See details»
Aura Biosciences Reports Fourth Quarter and Full Year 2024 …
1 day ago Research and development expenses increased to $22.3 million and $73.3 million for the three months and full year ended December 31, 2024, respectively, from $20.3 million and …See details»
Aura Biosciences Reports Positive Phase 1 Trial Results in Non
16 hours ago Aura Biosciences, Inc. recently presented positive Phase 1 trial results for its investigational treatment, bel-sar, targeting non-muscle invasive bladder cancer (NMIBC) at …See details»
Andelyn Biosciences Selected by Hubble Therapeutics to …
COLUMBUS, Ohio, Oct. 9, 2024 /PRNewswire/ -- Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization …See details»
Co-Founder & CEO @ Hubble Biosciences - Crunchbase
Primary Organization . Hubble Biosciences . Gender Female; Andrea McBeth is the Co-Founder and Chief Executive Officer of Hubble Biosciences. Jobs. Edit Jobs Section. Number of …See details»